Breast cancer (BC) is the most frequent cancer diagnosed in women worldwide. This
heterogeneous disease can be classified into four molecular subtypes (luminal A, luminal B …

Breast cancer is increasingly prevalent in older adults and is a substantial part of routine
oncology practice. However, management of breast cancer in this population is challenging …

PURPOSE To provide recommendations on the best strategies for the management and on
the best timing and treatment (surgical and radiotherapeutic) of the axilla for patients with …

Background Breast cancer mortality in European women has been falling for three decades.
We analysed trends in mortality from breast cancer in Europe over the period 1980–2017 …

Ethnopharmacological relevance Cancer is a major health problem worldwide. Drugs' side
effects and high cost of treatment remain the main limitations of conventional therapy …

Simple Summary Triple-negative breast cancer (TNBC) is a highly aggressive subtype of
breast cancer that cannot be treated with endocrine therapy and Her2-targeted therapy …

Simple Summary The 5-year survival rate for patients with breast cancer, in whom disease
has spread to local lymph nodes, is 85%. However, many live with the complications of …

Radiation therapy (RT) is an essential component in the management of breast cancer.
Following breast-conserving surgery (BCS), adjuvant RT is the standard of care for most …

The current review paper was written in collaboration with breast cancer surgeons from the
European Breast Cancer Research Association of Surgical Trialists (EUBREAST), a breast …

Background Radiotherapy is a conventional and effective local treatment for breast cancer.
However, residual or recurrent tumors appears frequently because of radioresistance. Novel …